Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125071763 | 12507176 | 3 | F | 20160909 | 20160629 | 20160921 | EXP | AR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119242 | RANBAXY | 34.00 | YR | F | Y | 0.00000 | 20160921 | MD | AR | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125071763 | 12507176 | 1 | SS | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125071763 | 12507176 | 2 | PS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | 350 MG, DAILY | Y | N | 75713 | 350 | MG | ||||||
| 125071763 | 12507176 | 3 | SS | Levomepromazine | LEVOMEPROMAZINE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125071763 | 12507176 | 1 | Product used for unknown indication |
| 125071763 | 12507176 | 2 | Product used for unknown indication |
| 125071763 | 12507176 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125071763 | 12507176 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125071763 | 12507176 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |